Actively Recruiting
Prevention of Constipation in Cancer Patients
Led by Marmara University · Updated on 2025-06-05
146
Participants Needed
1
Research Sites
33 weeks
Total Duration
On this page
Sponsors
M
Marmara University
Lead Sponsor
I
Istanbul University - Cerrahpasa
Collaborating Sponsor
AI-Summary
What this Trial Is About
Constipation is the third most common symptom in patients undergoing chemotherapy, with an incidence rate ranging from 31% to 90%. Despite its high prevalence and adverse effects on patients, constipation is often not reported by patients and is not frequently monitored by nurses, resulting in delays in treatment and care. Prolonged constipation can lead to health problems such as fecal impaction/obstruction, hemorrhoids, rectal pain, and intestinal perforation, thereby reducing patients' quality of life. Additionally, increased severity of constipation in cancer patients may lead to the interruption or complete cessation of chemotherapy. Therefore, it is essential to monitor and assess patients for the risk of developing constipation and to implement an effective nursing care protocol. Abdominal massage is an approach that increases peristalsis, i.e., digestive system movement, by altering intra-abdominal pressure, thereby reducing the severity of constipation.
CONDITIONS
Official Title
Prevention of Constipation in Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Receiving chemotherapy for breast cancer or lung cancer that causes constipation
- Patients who received at least one cycle of chemotherapy and experienced chemotherapy-associated constipation within five days of treatment (stool type 1 or 2 according to the Bristol Stool Scale)
- Volunteers who are willing to participate in the research, can communicate, and can read and write
- Without psychiatric illness and abdominal obstruction
- No mass in the abdominal region was detected
- No intestinal bleeding
- No history of radiation therapy to the abdominal region
- No surgical procedures in the abdominal region
- Patients without intra-abdominal infection, inflammatory bowel disease and irritable bowel syndrome will be included
You will not qualify if you...
- Patients with stool type 3, 4, 5, 6 and 7 points according to the Bristol Stool Scale
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istanbul University-Cerrahpasa Florence Nightingale Faculty of Nursing
Istanbul, Marmara, Turkey (Türkiye), 34381
Actively Recruiting
Research Team
C
CAN LAFÇI, PhD(c)
CONTACT
G
Gülbeyaz CAN, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here